Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2005
03/10/2005US20050054629 Antiproliferative agents; anticancer agents; restenosis
03/10/2005US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054618 Hypotensive agents; antiischemic agents; antiarrhythmia agents
03/10/2005US20050054605 Partial or full A1 agonists - N6 heterocyclic 5' thio substituted adenosine derivatives
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054593 New drug
03/10/2005US20050054591 Yin yang-1
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053705 Soluble soy protein with superior functional properties
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053548 Degrading collagen within an atherosclerotic plaque in a chronically occluded animal tube or cavity by administering proteolytic enzyme; angioplasty
03/10/2005CA2537928A1 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
03/10/2005CA2537535A1 Novel medical use of selective cb1-receptor antagonists
03/10/2005CA2537349A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005CA2537180A1 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
03/10/2005CA2537178A1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
03/10/2005CA2536784A1 Process for the production of polymorphs of rosiglitazone maleate
03/10/2005CA2536459A1 Pentafluorosulfanyl phenyl-substituted benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing said compounds
03/10/2005CA2533690A1 Use of a polyamine-poor composition for the production of a medical human food
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease
03/09/2005EP1512679A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
03/09/2005EP1512412A1 Method to identify anti-apoptotic compounds
03/09/2005EP1512410A1 Use of a composition for treating organ tissue injury caused by reperfusion of blood flow following a period of ischemia
03/09/2005EP1512407A1 Use of fermented glycine max (L.) extract in inhibiting 15-lipoxygenase
03/09/2005EP1512403A1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
03/09/2005EP1512398A1 Intravascular stent with cytoskeletal inhibitors for the prevention of restenosis
03/09/2005EP1512328A1 Soluble soy protein with superior functional properties
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511723A1 Sulfone liver x-receptor modulators
03/09/2005EP1511719A1 Amide derivatives as inhibitors of the enzymatic activity of renin
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511517A1 Formulation for parenteral administration of sodium channel blockers
03/09/2005EP1511512A1 Novel uses of parapoxvirus preparations
03/09/2005EP1511507A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
03/09/2005EP1511503A1 Use of a preparation produced from plant seedlings, enriched with electrolyte
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511487A1 Novel formulation for the parenteral application of crobenetine
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1511483A2 Methods of treatment with lxr modulators
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511468A1 Nanoparticulate sterol formulations and sterol combinations
03/09/2005EP1511467A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
03/09/2005EP1511379A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
03/09/2005EP1432407B1 Lisinopril compositions having large-particle dcpd
03/09/2005EP1345892B1 Acylaminoalkyl-substituted benzenesulfonamide derivatives
03/09/2005EP1272499B1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
03/09/2005EP1202969B1 Biphenyl derivatives, production thereof and use as medicines
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP1054670B1 Use of chelating agents in the treatment of atherosclerotic conditions
03/09/2005EP1003501B1 Use of an agent for lowering the risk of cardiovascular disease
03/09/2005EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
03/09/2005EP0935471B1 Mononuclear phagocytes in therapeutic drug delivery
03/09/2005EP0842273B1 Receptor ligand vegf-c
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005CN1592755A Anti-angiogenic peptides
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592745A Therapeutic chromone compounds
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592743A Inhibitors of glycogen synthase kinase 3
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592638A Promoters exhibiting endothelial cell specificity and methods of using same
03/09/2005CN1592637A Medicinal compositions
03/09/2005CN1592634A Non-neurotoxic plasminogen activating factors for treating stroke
03/09/2005CN1592620A Treating and preventing method of disease relative to cardiac insulin resistance
03/09/2005CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/09/2005CN1590547A Encoding gene sequence of nereid kinase possessing embolus dissolving activity and its amino acid sequence
03/09/2005CN1590383A Rod sage root extract and making method of its preparation
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
03/09/2005CN1589908A Tenascin-C nucleic acid ligands
03/09/2005CN1589889A Extract of plant dendrobii caulis and preparing process and use thereof
03/09/2005CN1589886A Eight ingredient aquilaria capsule and its preparation method
03/09/2005CN1589877A Ready prepared Chinese medicine for treating angeitis and preparation process
03/09/2005CN1589869A Depression of 15- lipoxidase using soya bean fermentation extract
03/09/2005CN1589867A Medicine for treating acute brain blood vessel disease and its preparation method
03/09/2005CN1589863A Compound hemorrhoid dispersing powder and its processing method
03/09/2005CN1589860A Chinese medicinal composition for treating hemorrhoid
03/09/2005CN1589855A Application of red sage root and its prepatation in making medicine for treating aspirin resistance blood vessel disease
03/09/2005CN1589845A Preparation technology of crataegus total phenolic acid portion and application
03/09/2005CN1589835A Mulberry leaf extract and its use
03/09/2005CN1589833A Medicine for treating high blood pressure and its preparation method
03/09/2005CN1589831A Miao nationality medicine ointment for treating skin disease
03/09/2005CN1589811A Medicinal composition, its preparation method and its use
1 ... 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 ... 1595